Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COIN phase III trial in first-line metastatic colorectal cancer
ISRCTN27286448Phase 3Completed
- Sponsor
- Medical Research Council
- Start
- Aug 2003
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
01
Overview
Phase 3, randomised, open-label trial of cetuximab, oxaliplatin, capecitabine, fluorouracil and folinic acid in metastatic colorectal adenocarcinoma (mCRC) (3 arms), sponsored by Medical Research Council. Started Aug 2003; status: completed.
02
Drugs
cetuximaboxaliplatincapecitabinefluorouracilfolinic acid
03
Conditions
metastatic colorectal adenocarcinoma (mCRC)
Beyond the preview
Go deeper on ISRCTN27286448.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN27286448.